Chia Kim Huat, Danny Lim and Penelope Loh from the Corporate & Capital Markets Practice acted as Singapore counsel for China Animal Healthcare Ltd (“China Animal Healthcare”) in its listing by way of introduction on the Main Board of The Stock Exchange of Hong Kong Limited (“SEHK”). The shares of China Animal Healthcare will commence trading on the SEHK on 21 December 2010.
Macquarie Securities Capital Limited acted as sole sponsor (“Sole Sponsor”). Deacons, Jingtian & Gongcheng and Conyers, Dill & Pearman acted as Hong Kong, PRC and Bermuda counsels, respectively, to China Animal Healthcare. Shearman & Sterling and Jun He Law Offices acted as Hong Kong and PRC counsels, respectively, to the Sole Sponsor. Moore Stephens were the reporting accountants.
China Animal Healthcare is a leading animal drug manufacturer in the PRC focusing on the manufacture, sale and distribution of compound chemical drugs and biological drugs.
Related Posts:
- None Found